Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Superior vena cava syndrome.

L J Wudel1, J C Nesbitt

  • 1Vanderbilt University Medical Center and St. Thomas Hospital, 4230 Harding Road, Nashville, TN 37205, USA.

Current Treatment Options in Oncology
|June 12, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bile duct injury following laparoscopic cholecystectomy: a cause for continued concern.

The American surgeon·2001
Same author

Symptomatic persistent post-coronary artery bypass graft pleural effusions requiring operative treatment : clinical and histologic features.

Chest·2001
Same author

Primary liposarcoma of the mediastinum.

AJR. American journal of roentgenology·2000
Same author

Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53).

Cancer gene therapy·2000
Same author

Intensive chemotherapy and radical resections for primary nonseminomatous mediastinal germ cell tumors.

The Annals of thoracic surgery·2000
Same author

Surgical management of early stage lung cancer.

Seminars in surgical oncology·2000

Superior vena cava syndrome (SVCS), often caused by lung cancer, requires prompt diagnosis and individualized treatment. Management options include chemotherapy, radiotherapy, endovascular stenting, or surgery, depending on the underlying cause.

Area of Science:

  • Oncology
  • Vascular Medicine
  • Thoracic Surgery

Background:

  • Superior vena cava syndrome (SVCS) is a critical condition often linked to lung cancer.
  • SVCS is typically not an oncologic emergency unless airway compromise is present.
  • Timely recognition and management are crucial for patient outcomes.

Purpose of the Study:

  • To outline the diagnostic and management strategies for superior vena cava syndrome (SVCS).
  • To emphasize the importance of individualized treatment based on the etiology of SVCS.
  • To review current and emerging treatment modalities for SVCS secondary to lung cancer.

Main Methods:

  • Review of current literature on SVCS diagnosis and treatment.
  • Analysis of treatment approaches based on the underlying cause of obstruction.

Related Experiment Videos

  • Evaluation of chemotherapy, radiotherapy, endovascular stenting, and surgical interventions.

    • Main Results:

    • Lung cancer is the predominant cause of SVCS.
    • Chemotherapy and radiotherapy are effective for SVCS in lung cancer patients.
    • Percutaneous endovascular stenting of the superior vena cava (SVC) is an increasingly utilized primary treatment.
    • Lytic agents are effective for thrombotic occlusion, and surgical decompression offers a solution in rare cases.

    Conclusions:

    • Treatment for SVCS must be individualized and guided by a confirmed diagnosis.
    • Multimodal treatment strategies, including oncologic therapies and interventional procedures, are key to managing SVCS.
    • Advances in endovascular techniques and surgical options provide effective solutions with low morbidity.